Comparison of the pharmacological effects of paricalcitol and doxercalciferol on the factors involved in mineral homeostasis

International Journal of Endocrinology

Volumn 2010, Issue , 2010, Pages

  Wu Wong, J Ruth ^a   Nakane, Masaki ^b   Gagne, Gerard D ^c   Brooks, Kristin A ^c   Noonan, William T ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b VidaGene   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; DOXERCALCIFEROL; MESSENGER RNA; MINERAL; PARATHYROID HORMONE; PARICALCITOL; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM BLOOD LEVEL; CELL NUCLEUS; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; HOMEOSTASIS; HYPERPHOSPHATEMIA; MALE; NEPHRECTOMY; NONHUMAN; PARATHYROID CELL; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SWINE;

EID: 79952220702     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2010/621687     Document Type: Article

References (13)

1. Andress D. L., Vitamin D treatment in chronic kidne (Pubitemid 41166535)
2. Brown A. J., Dusso A. S., Slatopolsky E., Vitamin D analogues for secondary hyperparathyroidism Nephrology Dialysis Transplantation 2002 17 supplement 10 10 19 (Pubitemid 35277070)
3. Carlberg C., Quack M., Herdick M., Bury Y., Polly P., Toell A., Central role of VDR conformations for understanding selective actions of vitamin D3 analogues Steroids 2001 66 35 213 221 (Pubitemid 32140898)
4. Jones G., Strugnell S. A., DeLuca H. F., Current understanding of the molecular actions of vitamin D Physiological Reviews 1998 78 4 1193 1231 (Pubitemid 28491953)
5. Brown A. J., Berkoben M., Ritter C. S., Slatopolsky E., Binding and metabolism of 1,25-dihydroxyvitamin D3 in cultured bovine parathyroid cells Endocrinology 1992 130 1 276 281
6. Brandi M. L., Fitzpatrick L. A., Coon H. G., Aurbach G. D., Bovine parathyroid cells: cultures maintained for more than 140 population doublings Proceedings of the National Academy of Sciences of the United States of America 1986 83 6 1709 1713 (Pubitemid 16018633)
7. Slatopolsky E., Cozzolino M., Finch J. L., Differential effects of 19-nor-1,25- (OH)2D2 and 1 -hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats Kidney International 2002 62 4 1277 1284
8. Slatopolsky E., Cozzolino M., Lu Y., Efficacy of 19-nor-1,25- (OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia Kidney International 2003 63 6 2020 2027 (Pubitemid 36605813)
9. Joist H. E., Ahya S. N., Giles K., Norwood K., Slatopolsky E., Coyne D. W., Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients Clinical Nephrology 2006 65 5 335 341 (Pubitemid 43676418)
10. Brown A. J., Coyne D. W., Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism Treatments in Endocrinology 2002 1 5 313 327 (Pubitemid 37047236)
11. Slatopolsky E., Finch J., Ritter C., Takahashi F., Effects of 19-nor-1,25 (OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats American Journal of Kidney Diseases 1998 32 2, supplement 2 S40 S47
12. Karmali R., Farrow S., Hewison M., Barker S., ORiordan J. L. H., Effects of 1,25-dihydroxyvitamin D3 and cortisol on bovine and human parathyroid cells Journal of Endocrinology 1989 123 1 137 142 (Pubitemid 19254943)
13. Anderson M. G., Nakane M., Ruan X., Kroeger P. E., Wu-Wong J. R., Expression of VDR and CYP24A1 mRNA in human tumors Cancer Chemotherapy and Pharmacology 2006 57 2 234 240 (Pubitemid 41779843)